Medicare Enrolled

Dr. Chirag Patel, M.D.

Neurology · Los Angeles, CA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Speaking/Promotional
1520 SAN PABLO STREET, Los Angeles, CA 90033
3234425710
In practice since 2011 (15 years)
NPI: 1285923201 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Patel from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Patel? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Patel

Dr. Chirag Patel is a neurology specialist in Los Angeles, CA, with 15 years of NPI registration. Based on federal Medicare data, Dr. Patel performed 28,592 Medicare services across 592 unique beneficiaries.

Between the years covered by Open Payments, Dr. Patel received a total of $52,304 from 27 pharmaceutical and/or device companies across 356 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Patel is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 15 years in practice ▲ Top 3% volume in CA $52,304 industry payments

Medicare Practice Summary

Medicare Utilization ↗
28,592
Medicare services
Top 3% in CA for neurology
592
Unique beneficiaries
$9
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~1,906 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Botox injection, per unit
An injection of onabotulinumtoxinA, a medication used to temporarily relax muscles or reduce gland activity. The dose is measured in units, with this code representing a single unit administered.
27,500 $5 $10
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
375 $111 $306
Bilateral facial and neck nerve muscle paralysis injection
Injection of a chemical agent to paralyze muscles in the face and neck on both sides.
142 $142 $650
New patient office visit, complex (60-74 min) 93 $198 $546
Intravenous infusion, 1 hour or less
Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less.
88 $67 $267
Magnesium sulfate injection, per 500 mg
An injection of magnesium sulfate administered in 500 mg increments.
88 $1 $5
Injection of anesthetic or steroid into upper neck and back of head nerve
An injection of an anesthetic agent and/or steroid into a nerve located in the upper neck and back of the head.
72 $100 $325
Trigger point injection, 3 or more muscles
Injection of medication into three or more specific muscle trigger points to relieve pain.
67 $31 $286
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
52 $162 $390
Injection, methylprednisolone acetate, 40 mg 45 $6 $20
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
26 $149 $429
Ketorolac injection, per 15 mg
An injection of ketorolac tromethamine, a nonsteroidal anti-inflammatory drug, administered in doses measured per 15 mg.
23 $0 $12
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
21 $14 $78
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.3% high complexity
97.8% medium
1.9% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$52,304
Total received (2018-2024)
Avg $7,472/year across 7 years
Top 9% in CA for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
27
Companies
356
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$48,846 (93.4%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,458 (6.6%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$16,347
2023
$6,778
2022
$12,210
2021
$11,244
2020
$4,787
2019
$741
2018
$197

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$15,200
Neurocrine Biosciences, Inc.
$587
UCB, Inc.
$172
Teva Pharmaceuticals USA, Inc.
$93
Alexion Pharmaceuticals, Inc.
$63
Amneal Pharmaceuticals LLC
$56
Eisai Inc.
$40
SCILEX PHARMACEUTICALS INC.
$39
Canon Medical Systems USA, Inc.
$24
Kyowa Kirin, Inc.
$22
Lilly USA, LLC
$22
PFIZER INC.
$15
Amgen Inc.
$15
Top 3 companies account for 97.6% of 2024 payments
All-time payments by company (2018-2024) ›
ABBVIE INC.
$28,020
Allergan, Inc.
$12,313
Biohaven Pharmaceutical Holding Company Ltd.
$5,356
Biohaven Pharmaceuticals, Inc.
$3,172
Teva Pharmaceuticals USA, Inc.
$711
Neurocrine Biosciences, Inc.
$587
Amgen Inc.
$327
AbbVie Inc.
$259
Amneal Pharmaceuticals LLC
$243
UCB, Inc.
$227
PFIZER INC.
$195
Bausch Health US, LLC
$155
Kyowa Kirin, Inc.
$146
Biogen, Inc.
$103
Rigel Pharmaceuticals, Inc.
$95
Alexion Pharmaceuticals, Inc.
$63
Eisai Inc.
$59
Supernus Pharmaceuticals, Inc.
$42
SCILEX PHARMACEUTICALS INC.
$39
Genentech USA, Inc.
$35
MITSUBISHI TANABE PHARMA AMERICA, INC.
$33
Canon Medical Systems USA, Inc.
$24
Alnylam Pharmaceuticals Inc.
$22
Lilly USA, LLC
$22
Novartis Pharmaceuticals Corporation
$21
Scilex Pharmaceuticals Inc.
$21
Promius Pharma LLC
$15
Top 3 companies account for 87.4% of all-time payments
Associated products mentioned in payments ›
AIMOVIG · AJOVY · AMVUTTRA · AMYVID · AUSTEDO · Aimovig · Austedo XR · BOTOX · BOTOX COSMETIC · Briviact · COMIRNATY · CREXONT · ELYXYB - CELECOXIB · Enspryng · INGREZZA · INTERVENTIONAL ANGIOGRAPHY SYSTEM · Leqembi · MIGRANAL · NOURIANZ · NURTEC ODT · Nourianz · Ocrevus · PAXLOVID · QULIPTA · RADICAVA · RYTARY · Rezlidhia · TECFIDERA · TROKENDI XR · UBRELVY · ULTOMIRIS · ZTLido · Zembrace
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (93%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in neurology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 9% for neurology in CA.

Looking for a neurology specialist in Los Angeles?
Compare neurologists in the Los Angeles area by procedure volume, costs, and industry payment transparency.
Browse neurologists nearby

Geographic Context

Neurologists within 10 mi
578
Per 100K population
5.9
County median income
$87,760
Nearest hospital
ADVENTIST HEALTH WHITE MEMORIAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Patel is a mixed practice specialist, with above-average Medicare volume (top 3% in CA), with speaking/promotional industry engagement in the top 9% of CA peers, with 15 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Patel experienced with botox injection, per unit?
Based on Medicare claims data, Dr. Patel performed 27,500 botox injection, per unit services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Patel receive payments from pharmaceutical companies?
Yes. Dr. Patel received a total of $52,304 from 27 companies across 356 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Patel's costs compare to other neurologists in Los Angeles?
Dr. Patel's average Medicare payment per service is $9. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Patel) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →